A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer

Demirkol, Secil; Gomceli, Ismail; Isbilen, Murat; Dayanc, Baris; Tez, Mesut; Bostanci, Erdal; Turhan, Nesrin; Akoglu, Musa; Ozyerli, Ezgi; Durdu, Sevi; Konu, Ozlen; Nissan, Aviram; Gonen, Mithat; Gure, ALİ

doi:10.7150/jca.17872

A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer

Copy For Citation

Demirkol S., Gomceli I., Isbilen M., Dayanc B. E. , Tez M., Bostanci E. B. , ...More

JOURNAL OF CANCER, vol.8, no.7, pp.1113-1122, 2017 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 8 Issue: 7
Publication Date: 2017
Doi Number: 10.7150/jca.17872
Title of Journal : JOURNAL OF CANCER
Page Numbers: pp.1113-1122

Abstract

Background: Prognostic biomarkers for cancer have the power to change the course of disease if they add value beyond known prognostic factors, if they can help shape treatment protocols, and if they are reliable. The aim of this study was to identify such biomarkers for colon cancer and to understand the molecular mechanisms leading to prognostic stratifications based on these biomarkers.